Pimecrolimus for the Treatment of Adults with Atopic Dermatitis, Seborrheic Dermatitis, or Psoriasis: A Review of Clinical and Cost-Effectiveness [Internet].

Due to the expanded clinical use of pimecrolimus, a review of both the evidence of its efficacy and of its potential economic evaluation is of importance for a more evidence- based clinical and policy decision making process. This is particularly relevant in reference to three clinical conditions: adult atopic dermatitis, adult seborrheic dermatitis, and adult psoriasis.

https://ift.tt/2KfTm7W